Literature DB >> 15032678

The emergence of selective 5-HT 2B antagonists structures, activities and potential therapeutic applications.

G Poissonnet1, J G Parmentier, J A Boutin, S Goldstein.   

Abstract

5-HT(2) receptors mediate a large array of physiological and behavioral functions in humans via three distinct subtypes: 5-HT(2A), 5-HT(2B)and 5-HT(2C). While selective 5-HT(2A)antagonists have been known for some time, knowledge of the precise role played by the 5-HT(2B)receptor was hampered by the existence of solely 5-HT(2B)5-HT(2C) mixed antagonists. However, selective 5-HT(2B)antagonists began recently to emerge in the literature. Indeed, four structural classes belonging to the piperazine, indole, naphthylpyrimidine and tetrahydro-beta-carboline scaffolds were reported. In this paper, we will briefly review the structural and pharmacological features of selective 5-HT(2B) antagonists, including patent literature of the last five years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032678     DOI: 10.2174/1389557043487312

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  4 in total

Review 1.  Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease.

Authors:  Terry-Elinor Reid; Krishna Kumar; Xiang Simon Wang
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

2.  Exploring Halogen Bonds in 5-Hydroxytryptamine 2B Receptor-Ligand Interactions.

Authors:  Yu Zhou; Yuanxun Wang; Pengfei Li; Xi-Ping Huang; Xiangbin Qi; Yunfei Du; Niu Huang
Journal:  ACS Med Chem Lett       Date:  2018-10-01       Impact factor: 4.345

3.  Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.

Authors:  Moustafa T Gabr; Mohammed S Abdel-Raziq
Journal:  Medchemcomm       Date:  2018-05-21       Impact factor: 3.597

Review 4.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.